Ce3-Contract Research Organisation for Early Development of First-in-Human Oncology Clinical Trials

Ce3 is a full-service oncology contract research organisation (CRO) focused on first-in-human Phase 1-2a development programmes in the biopharmaceutical area.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news